Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels
Atherosclerosis, 06/25/09
Otokozawa S et al. - The findings utilizing a specific immunoassay and a fairly large number of subjects extend prior studies indicating that statins significantly lower apolipoprotein B containing lipoproteins of both intestinal and liver origin.
Related Articles
Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice
Current Medical Research and Opinion, 10/22/09
Relevance Score: 92%
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 89%
Rosuvastatin Attenuates Ang II—Mediated Cardiomyocyte Hypertrophy via Inhibition of LOX-1
Journal of Cardiovascular Pharmacology and Therapeutics, 11/18/09
Relevance Score: 84%
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin
JACC - Journal of the American College of Cardiology, 11/05/09
Relevance Score: 83%
Treating cholesterol: Drugs and natural options
Internet Source, 10/09/09
Relevance Score: 77%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Ageing and cardiovascular responses to head-up tilt in healthy subjects
Atherosclerosis, 12/04/09
Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA study
Atherosclerosis, 12/04/09
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study
Atherosclerosis, 12/04/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury
Atherosclerosis, 12/04/09
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD: a systematic review and meta-analysis
European Respiratory Journal , 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


